Abbott Laboratories (ABT)

Gross profit margin

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Gross profit	US$ in thousands	23,244,000	22,134,000	24,511,000	24,538,000	19,605,000
Revenue	US$ in thousands	41,950,000	40,109,000	43,653,000	43,075,000	34,608,000
Gross profit margin		55.41%	55.18%	56.15%	56.97%	56.65%

December 31, 2024 calculation

Gross profit margin = Gross profit ÷ Revenue
= $23,244,000K ÷ $41,950,000K
= 55.41%

Based on the provided data, Abbott Laboratories has maintained a relatively stable gross profit margin over the past five years. The gross profit margin shows the percentage of revenue that exceeds the cost of goods sold, indicating the company's efficiency in managing production costs.

In December 2020, Abbott Laboratories had a gross profit margin of 56.65%, which slightly increased to 56.97% by December 2021. However, there was a slight decline in the gross profit margin to 56.15% by December 2022, followed by a more notable decrease to 55.18% by December 2023. In the most recent year, December 2024, the gross profit margin saw a slight improvement to 55.41%.

Despite some fluctuations, Abbott Laboratories has generally maintained a gross profit margin above 55% throughout the period, indicating effective cost management and pricing strategies. It is important for the company to monitor any significant changes in the gross profit margin to ensure profitability and competitiveness in the market.